(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 42.34%-1.63M | -407.69%-11.69M | -3.43%-3.33M | 96.10%-1.53M | 172.06%6.82M | 75.65%-2.82M | 74.01%-2.3M | 64.99%-3.22M | -24.41%-39.11M | -29.77%-9.46M |
Net income from continuing operations | -138.51%-5.27M | -81.23%-7.03M | 82.98%-680.81K | 61.67%-15.75M | 45.59%-5.67M | 60.23%-2.21M | 67.63%-3.88M | 69.58%-4M | -15.87%-41.1M | -46.67%-10.41M |
Operating gains losses | 1,002.65%2.63M | 709.88%3.2M | -1,315.98%-1.79M | 132.95%801.66K | 333.34%824.65K | 86.75%-291.37K | 210.22%394.55K | -91.78%-126.17K | -84.55%-2.43M | 113.58%190.3K |
Depreciation and amortization | -16.08%79.03K | -83.45%16.2K | -15.39%165.3K | 25.72%363.74K | -125.34%-23.74K | 124.01%94.18K | -6.43%97.93K | 299.10%195.38K | 50.90%289.34K | 1,253.68%93.69K |
Securities amortization | --199.99K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Asset impairment expenditure | ---- | ---- | ---- | 222.79%1.29M | ---- | ---- | ---- | ---- | ---1.05M | ---1.32M |
Unrealized gains and losses of investment securities | 39.70%77.72K | -58.67%81.9K | -279.05%-127.44K | -49.01%316.42K | -269.58%-8.55K | -88.15%55.63K | -54.70%198.16K | 124.43%71.18K | 48.65%620.59K | -98.53%5.04K |
Remuneration paid in stock | -61.88%922.21K | -18.85%947.54K | -14.26%881.5K | -38.37%5.67M | -26.61%1.06M | 44.66%2.42M | -33.98%1.17M | -76.21%1.03M | 35.64%9.21M | 28.63%1.44M |
Deferred tax | --0 | --0 | --0 | ---- | ---- | 32.56%-3.36M | -41.86%546.13K | -4.93%727.69K | ---- | ---- |
Other non cashItems | ---- | --70.08K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Change In working capital | -157.17%-269.17K | -984.72%-8.97M | -59.44%-1.79M | 224.56%5.78M | 364.79%7.25M | 145.80%470.83K | -2,593.55%-826.65K | -33.34%-1.12M | -50.59%-4.64M | -2,092.60%-2.74M |
-Change in receivables | 114.21%134.49K | 65.03%-234.74K | -57.45%-772.96K | 196.04%4.62M | 586.02%6.73M | 48.77%-946.59K | 29.67%-671.33K | 21.44%-490.93K | -30.51%-4.81M | -1,053.86%-1.38M |
-Change in prepaid assets | 5,656.60%124.69K | -25.80%-225.51K | -43.54%41.59K | 16.12%-32.78K | 50.30%70.67K | -96.48%2.17K | 16.38%-179.27K | 10.25%73.66K | 67.83%-39.08K | 28.09%47.02K |
-Change in payables and accrued expense | -137.33%-528.36K | -35,619.43%-8.51M | -50.04%-1.06M | 461.23%1.19M | 132.39%454.11K | 86.64%1.42M | -97.90%23.95K | -149.10%-703.39K | -70.87%212.02K | -3,266.03%-1.4M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 42.34%-1.63M | -407.69%-11.69M | -3.43%-3.33M | 96.10%-1.53M | 172.06%6.82M | 75.65%-2.82M | 74.01%-2.3M | 64.99%-3.22M | -24.41%-39.11M | -29.77%-9.46M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 47.15%-3.11M | 80.55%-2.93M | 24.27%-4.45M | -331.35%-33.76M | -9,828.02%-6.93M | -4,131.33%-5.89M | -201.37%-15.06M | -10,392.24%-5.88M | 347.90%14.59M | 55.20%-69.82K |
Net PPE purchase and sale | 47.15%-3.11M | 80.55%-2.93M | 24.27%-4.45M | -8,162.35%-33.76M | -9,828.02%-6.93M | -4,131.33%-5.89M | -10,386.44%-15.06M | -10,392.24%-5.88M | 93.06%-408.57K | 55.20%-69.82K |
Net investment purchase and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --15M | --0 |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 47.15%-3.11M | 80.55%-2.93M | 24.27%-4.45M | -331.35%-33.76M | -9,828.02%-6.93M | -4,131.33%-5.89M | -201.37%-15.06M | -10,392.24%-5.88M | 347.90%14.59M | 55.20%-69.82K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 3,320.07%755.2K | -98.36%801.9K | -113.59%-23.92K | 237.50%48.85M | -115.10%-73.66K | -101.58%-23.45K | 325.38%48.77M | -83.01%176.05K | -40.22%14.48M | -89.19%487.91K |
Net issuance payments of debt | -4.03%-24.4K | -4.02%-24.16K | -25.58%-23.92K | -183.36%-139.39K | -385.02%-73.66K | -136.61%-23.45K | -91.85%-23.22K | -58.92%-19.05K | -5.15%-49.19K | -27.96%-15.19K |
Net common stock issuance | --0 | --0 | ---- | --48.74M | --0 | --0 | --48.74M | ---- | --0 | --0 |
Proceeds from stock option exercised by employees | --779.6K | 1,359.46%826.06K | --0 | -98.27%251.7K | --0 | --0 | -99.51%56.6K | -81.39%195.1K | -40.14%14.52M | -88.88%503.1K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 3,320.07%755.2K | -98.36%801.9K | -113.59%-23.92K | 237.50%48.85M | -115.10%-73.66K | -101.58%-23.45K | 325.38%48.77M | -83.01%176.05K | -40.22%14.48M | -89.19%487.91K |
Net cash flow | ||||||||||
Beginning cash position | -45.65%37.05M | 36.04%50.7M | 27.53%58.94M | -15.58%46.22M | 7.88%59.93M | 7.17%68.17M | -19.37%37.27M | -15.58%46.22M | -18.95%54.75M | -3.62%55.55M |
Current changes in cash | 54.39%-3.98M | -143.98%-13.81M | 12.51%-7.81M | 235.17%13.57M | 97.95%-185.12K | 14.68%-8.73M | 79.86%31.41M | -8.52%-8.93M | 23.38%-10.04M | -208.24%-9.05M |
Effect of exchange rate changes | -23.59%375.26K | 130.34%157.01K | -2,120.69%-427.37K | -156.04%-847.06K | -180.85%-801.49K | -77.39%491.11K | -514.23%-517.43K | 93.39%-19.25K | 398.09%1.51M | -719.91%-285.38K |
End cash Position | -44.20%33.44M | -45.65%37.05M | 36.04%50.7M | 27.53%58.94M | 27.53%58.94M | 7.88%59.93M | 7.17%68.17M | -19.37%37.27M | -15.58%46.22M | -15.58%46.22M |
Free cash from | 45.59%-4.74M | 15.82%-14.62M | 14.39%-7.8M | 10.48%-35.37M | 97.88%-201.94K | 25.70%-8.7M | -92.89%-17.36M | 1.72%-9.11M | -5.88%-39.51M | -27.99%-9.53M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data